JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.
Zacks Small Cap Research on MSN3h
MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…(NASDAQ:MTVA) is currently conducting a Phase 1 clinical trial of DA-1726 in patients with obesity. In September 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback